Role of the Clinical Pharmacist in Multiple Myeloma Management

Kristen Peterson, PharmD, BCOP, reviews how pharmacists navigate multiple myeloma treatments, from initial diagnosis to managing adverse effects, supporting patients, ensuring medication access, and handling evolving roles in prolonged patient care.

Gabriel Hinojosa, PharmD, BCOP, analyzes eligibility factors and treatment shifts in multiple myeloma care, in addition to discussing autologous stem cell transplant risks and evolving therapy approaches with daratumumab.

Kristen Peterson, PharmD, BCOP, reviews how pharmacists collaborate with health care teams to optimize patient care through treatment insight, coordination, and adverse effects management, in addition to ensuring medication accessibility for better outcomes.

Gabriel Hinojosa, PharmD, BCOP, reviews head-to-head comparisons in multiple myeloma regimens and evaluates efficacy and safety implications in treatment selection.

Kristen Peterson, PharmD, BCOP, discusses how pharmacists optimize quality of life for patients with multiple myeloma, manage treatment adverse effects, and adapt amid health care shortages while staying updated on the latest advancements for comprehensive patient care.

Gabriel Hinojosa, PharmD, BCOP, provides insights on selecting the best treatment regimen, and considers comorbidities, adverse events, and therapy modifications in multiple myeloma treatment.

Kristen Peterson, PharmD, BCOP, explores how pharmacists deliver comprehensive education, empower patients, manage adverse effects, and prioritize outcomes for multiple myeloma care, ensuring quality treatment understanding and adherence.

Gabriel Hinojosa, PharmD, BCOP, looks beyond frontline regimens in multiple myeloma, and discusses treatment options, adverse events, and complexities in sequencing therapies.

Kristen Peterson, PharmD, BCOP, reviews pharmacists’ pivotal role in optimizing patient transitions between inpatient and outpatient care settings to ensure treatment continuity and medication management in multiple myeloma care.

Gabriel Hinojosa, PharmD, BCOP, explores unmet needs and social determinants in multiple myeloma care, envisioning treatment advancements amid evolving complexities and patient disparities.